RNAi THERAPEUTICS
We have our SKIN in the game
KoshKey develops RNA interference therapies that clear drug-resistant
infections and restart healing in chronic diabetic wound
About KoshKey
Government of India recognised
Government of India recognised
Government of India recognised
DPIIT Recognised Startup
DIPP106056
Peer-reviewed science
Government of India recognised
Government of India recognised
Published in Cell Reports, PLoS Biology and Frontiers in
Immunology
Grant-backed
Government of India recognised
ISO 9001:2015 certified
BIRAC Biotech Ignition Grant • ELEVATE Karnataka
ISO 9001:2015 certified
Government of India recognised
ISO 9001:2015 certified
Quality-managed research.
Quality systems developed in accordance with ISO/IEC 17025:2017 principles
About Us
Therapeutic Gene Modulation
Diabetic skin loses its ability to mount an antimicrobial response and initiate repair. Our in-house research identified the genes responsible.
RiboKOSH, our RNA interference platform, silences those genes and restarts the body's own wound-healing and antimicrobial programme in skin cells, clearing infection and accelerating healing at the same time. Read the science
Research Services
In-vitro, ex-vivo, and in-vivo skin models. Human and mouse keratinocytes, skin explants, and validated
disease mouse models for atopic dermatitis, psoriasis, and scleroderma.
Partner With Us
We co-develop with pharmaceutical, cosmeceutical and academic partners across oligonucleotide design, formulation and preclinical validation.
Incubation Partners and Grant Agencies
